Clinical Trial Update: Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Mayo Clinic–sponsored Phase 2 trial evaluating standard chemotherapy with or without stereotactic body radiation therapy for oligometastatic pancreatic cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 2 | Status: TERMINATED